ABSTRACT: Oxytocin (OT) is a neuropeptide that is produced primarily in the hypothalamus and is best known for its role in mammalian birth and lactation. Recent evidence also implicates OT in social behaviors, including parental behavior, the formation of social bonds, and the management of stressful experiences. OT is reactive to stressors, and plays a role in the regulation of both the central and autonomic nervous system, including effects on immune and cardiovascular function. Knowledge of patterns of OT release would be of value in many fields of science and medicine. However, measurements of OT concentration in blood are infrequently performed, and previous attempts to measure OT in saliva have been unsuccessful. Using a sensitive enzyme immunoassay (EIA) and concentrated samples we were able to detect reproducible changes in salivary OT as a function of lactation and massage. These results indicate that measurements of biologically relevant changes in salivary OT are possible. These results confirm the biological relevance of changes in salivary OT with stressors and support saliva as a noninvasive source to monitor central neuroendocrine function.
INTRODUCTION AND BACKGROUND
Oxytocin (OT) is a mammalian nonapeptide (FIG. 1) with functional roles in birth, lactation, parenting, and forms of positive social interactions. Treatment with OT quickly facilitates positive social behaviors, including selective partner preferences and parental behavior. 1, 2 OT receptors also correlate with positive social behavior. OT is made in and acts on the brain, primarily in the hypothalamus and areas of the nervous system that influence emotions and, as measured by mRNA levels, is the most abundantly expressed peptide in the hypothalamus. 5 OT is released during positive social interactions and may facilitate the ability to be vulnerable, feel safe, and relaxed by downregulating or buffering the response to stressors and the reactivity of the autonomic nervous system, including heart rate and blood pressure. 3, 4 OT's role is well established in birth, lactation, and parenting, as well as sexual interactions and stress management. For example, in rats, touch and massage may release OT. 3 OT released in the brain may feed back on the nervous system to further enhance relaxation or other coping mechanisms, in part through direct effects on behavior, but also through actions on the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. OT may have a protective role in the cardiovascular system, and can induce analgesia and facilitate wound healing, possibly through its anti-inflammatory actions, as well as effects on the autonomic nervous system. 3, 4 Thus OT is an excellent candidate biomarker for the coordination of emotional states and feelings with physiological processes through which positive social interactions bestow health benefits.
OT is unusual in its ability to integrate multiple actions. Of particular relevance to the broad effect of OT is the fact that this hormone has only one known type of receptor. 6 Most neurochemicals, including the related neuropeptide arginine vasopressin (AVP), have several receptor subtypes that allow a single biologically active molecule to have diverse functions. However, OT has the potential to interact with AVP and its receptors, and many other systems implicated in stress and coping. Although AVP is structurally similar to OT in that its sequence differs by only two amino acids, several of the known effects of AVP are opposite to those of OT. OT and the neural systems that it helps to regulate also may counteract the tendency to be defensive, fearful, or anxious.
1,2 For example, during lactation, OT is released in pulses that both facilitate milk ejection and also may reduce anxiety and overreactivity to stressful stimuli. 7, 8 Males also respond to OT: for example, a single treatment with an intranasal FIGURE 1. OT is a 9 amino acid cyclic peptide. The PVN and SON are the primary hypothalamic sources of oxytocin in the brain.
OT spray reduces reactivity to stressors, 9 and also increases the willingness of men to "trust" others, as measured in a computerized game. 10 Intranasal OT also has direct effects on neural activation of the amygdala in response to fear-inducing stimuli and was associated with reductions in neural activation of brainstem regions implicated in fear and arousal.
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CENTRAL VERSUS PERIPHERAL PEPTIDES
Research in rats suggests that the major sources of OT in the peripheral circulation are hypothalamic nuclei, including the paraventricular nucleus (PVN) and the supraoptic nucleus (SON). OT from both the SON and PVN is carried via axoplasmic transport to the posterior pituitary for release into the blood stream. OT from the posterior pituitary is presumed to be the primary source of salivary OT. The PVN also is a major source for centrally released OT, although some OT of SON origin may also be released into the brain. 6 The relationship between central and peripherally produced peptides is controversial. 12 On the basis of central microdialysis data from rats, it appears that central and peripheral release of OT tends to be coordinated, while there is dissociation between central and peripheral AVP. 13 In voles, we have also found significant positive correlations between OT immunoreactivity in the PVN and SON and peripheral levels of OT measured by enzyme immunoassay (EIA) (Bales and Carter, unpublished data). Such experiments are not possible in humans, but support the usefulness of measures of peripheral levels of OT as an index of OT central synthesis. Additional evidence for sites of OT's action outside the central nervous system (CNS) includes spinal cord and nonspinal pathways via the vagus, and synergistic interactions between OT and CCK, mediated through the vagus. 
RATIONALE: METHODOLOGICAL ISSUES IN THE STUDY OF NEUROPEPTIDES
Compelling results from animal models and the emerging data on behavioral effects of peptides in humans implicate OT in both behavior and physiology, 1, 2, 6 although, measurements of neuropeptides are rare because of technical difficulties associated with collecting human samples. Such testing would be facilitated by noninvasive methods for measuring peptides associated with naturally occurring behavioral events. Commercial radioimmunoassays (RIA) for neuropeptides require large amounts of sample (∼1 mL), and often require preanalytical chemical extraction that is associated with less than quantitative peptide recovery. Reported values for OT are frequently close to the level of detection for the assay and thus potentially result in a large experimental error.
FIGURE 2.
Oxytocin reactivity in prairie vole plasma samples. Comparison of oxytocin antibody specificities was made using HPLC separation and subsequent assay by either EIA (Assay Designs, Inc) or RIA (Peninsula, Bachem). OT elutes in the sixth fraction, while AVP elutes in the third fraction. Note that the EIA is more specific for OT levels since the RIA assay detects both AVP and OT.
Our research on the behavioral effects of OT in rodents necessitates dealing with amounts of sample that rendered the use of a RIA inadequate because of a lack of sensitivity. Consequently, we validated a commercial EIA 14 and used that with a preanalysis concentration step for human saliva. It was possible to measure OT above the detection limit of ∼5 pg/mL with improved sensitivity and specificity (FIG. 2) . However, there remains a need for improved sensitivity and assay technology.
METHODOLOGICAL ISSUES IN THE STUDY OF SALIVARY HORMONES
Salivary measures of biomarkers, such as steroid hormones, have over the last two decades become well accepted in human endocrinology. Most studies that relate salivary biomarkers to behavior have measured adrenal steroids (usually glucocorticoids) or gonadal hormones (testosterone, estrogen, or progesterone). This research has been productive and extensive databases are available describing the parameters of steroid hormones, including differences as a function of time of day of sampling, gender, age, and responses to stressors. 15 However, because these hormones originate primarily from tissue outside the nervous system they are at best only indirect measures of brain function. Neuropeptides such as OT that are primarily synthesized in the nervous system are more likely to be directly related to behavior.
Collection of saliva offers several advantages over blood, especially since this method is noninvasive, with few risks, and samples can be collected under both naturalistic and laboratory conditions. Steroid hormones in saliva are generally "free," while blood contains both free and protein-bound hormone. Collection can be made by the participant and, beyond the limitations of the participant's motivation and compliance, the frequency and time of the day of sampling are virtually unlimited. Samples can be frozen and briefly stored in a standard home freezer (without a thawing cycle), although a −80
• C freezer is required for long-term storage. 16 Several recent studies have identified methodological guidelines specific for the study of salivary hormones that suggest preferential collection from individuals who do not have mucosal sources of blood (bleeding gums, sores, etc). Recent brushing or flossing may release blood into saliva, 17 but microinjuries of the oral mucosa have little effect on the reliability of assays for cortisol.
Methods for collecting saliva that use either cotton or polyester may introduce variance into these assays. The impact of the collection method differs among hormones, but may be especially important when using an EIA. 16, 18 In addition, methods used to increase salivation, including flavor crystals and chewing gum, may change the oral pH or dilute the analyte. On the basis of the research of Granger and colleagues, 16, 17 saliva was collected by asking participants to "passively drool" into a cold collection tube and frozen immediately after collection.
It is possible that OT values from saliva may not be meaningfully related to other endocrine variables, including central peptides, which are of particular importance to behavior. As described above, most of the RIA commercial kits for OT require an extraction and large samples, and typical results are close to the limit of detection for the assay and consequently have not proven useful for salivary peptides.
VALIDATION OF THE EIA ASSAY FOR OXYTOCIN
Measurement and Validation of the EIA for Oxytocin
Oxytocin was measured using the EIA kit developed by Assay Designs, Inc. (Ann Arbor, MI, USA). Assay Designs reported a low cross-reactivity for similar neuropeptides found in mammalian sera at less than 0.001% (FIG. 2) and a minimum detection limit of 4.68 pg/mL. Manufacturer's instructions were followed without modification, although plasma was not extracted. Validation of the EIA was conducted using various methods 14 : parallelism was validated by measurements from a serial dilution of pooled vole plasma; accuracy of the assay was assessed by spiking samples of pooled vole plasma with varying amounts of standard; precision was determined from the variability surrounding multiple measurements of high and low controls (interassay CV) and variability in multiple measurements of unknowns (intra-assay CV); and in vivo determinations for biological validation were made in plasma from sexually naïve female prairie voles receiving a single subcutaneous injection of OT (5 g OT/50 L isotonic saline). Samples were collected prior to injection or at one of three time points after injection (5, 15, or 60 min). A dilution series of pooled vole plasma resulted in a displacement curve parallel to that of the standard curve (y = 129.88-16.79×; r 2 = 0.96). Tests of accuracy resulted in a high correlation between expected and observed values (y = −2.20 + 0.79×; r 2 = 1.00) and average recovery was 71%. Intra-assay CV averaged 2.68%; interassay CV averaged 14.45%; standard curves were similar across assays. Injection with OT resulted in a significant increase in plasma OT (P < 0.0001) with all pair-wise comparisons significant. Values were maximal 15 min following injection. Within 60 min, plasma OT was significantly lower (P < 0.0001), but still elevated over baseline levels (P < 0.0001).
Biological Validations in Blood: Species and Sex Differences
Prairie voles and rats of both sexes were used for comparisons to plasma OT. Blood samples for determination of baseline OT were collected from reproductively naïve male and female prairie voles (n =12 and 11, respectively) and male and female rats (n = 11 for each sex). There were significant differences in plasma OT by species and by sex, with voles having significantly higher OT than rats (P < 0.0001) and females having higher OT than males (P < 0.001). Female voles averaged 488.3 ± 87.6 pg/mL (n =11) and males, 264.4 ± 31.0 pg/mL (n =12). Female rats averaged 186.5 ± 53.4 pg/mL (n =11) and males, 78.9 ± 5.8 pg/mL (n =11).
On the basis of the parallelism data collected from initial measurements of plasma pools, plasma samples for both voles and rats were diluted 1:4 prior to assay (requiring 65 L of plasma to assay samples in duplicate). Vole plasma collected after injection with OT was initially diluted 1:4, but in all cases OT concentrations that were measured exceeded the highest standard used to generate the standard curve. A second aliquot was available for each vole, allowing reassay at a higher dilution factor. A 1:20 dilution resulted in values within the range of the standards. Measured concentrations for the serial dilution of pooled plasma were parallel to the standard curve, indicating that extraction procedures are unnecessary and that a 1:4 or higher dilution eliminates significant matrix effects. The OT assay also was valid in terms of quantitative recovery, with good agreement between expected and observed OT concentrations for spiked samples.
OT concentrations observed in this study were higher than those reported using RIA and extracted plasma. Recent studies of nonextracted rat blood and CSF, 19 primate CSF and blood, 20 and human blood, 21, 22 using the identical protocol produced OT values within the range of those measured in rodents in our lab. These laboratories also validated this assay (as described here) and found the same functional relationships. While it is difficult to quantitatively compare measurements between assays, especially using different assay systems, we assessed relative differences between species by comparison of split samples measured by both EIA and RIA (run courtesy of Dr. Janet Amico, University of Pittsburgh). The RIA had a range of 1-20 pg/mL. Results from this RIA showed that OT in rat plasma from our laboratory fell within the standard curve. However, all prairie vole plasma assayed by RIA far exceeded the standard curve, precluding comparisons of individual data. Results from both assays supported the hypothesis that prairie voles had significantly higher baseline OT levels and the usefulness of this assay.
Validation of EIA Antibody Specificity
To determine the specificity of the antibody used in the Assay Designs EIA, samples were chromatographed by high-performance liquid chromatography (HPLC) prior to immunoassay using previously described methods. 23 Samples were thawed and 200 L added to acidified buffer (800 L distilled water, 20 L phosphoric acid) and purified by solid-phase extraction (SepPak, C18, Waters, Milford, MA, USA). The method consisted of conditioning the column with 1 mL methanol and then 1 mL distilled water prior to adding the acidified sample. The sample was washed on the column with 1 mL 1% trifluoroacetic acid (TFA) in 10% acetonitrile (ACN), and eluted with 80% ACN in H 2 O. After drying, samples were reconstituted in 30 L of ACN:H 2 O (50:50) and 20 L injected onto a Beckman HPLC system using the method reported by Fries et al. 23 Samples were eluted and 1-mL fractions collected for the 10-min runs. Standard of AVP and OT (Sigma Chemical Co., St. Louis, MO, USA) were eluted in the third and sixth fraction, respectively. All fractions were divided into two aliquots, dried and reconstituted in buffer for either EIA (Assay Design) or OT RIA (Peninsula, Bachem, CA, USA). For three independent prairie vole samples, the OT EIA showed no reactivity with other fractions, except the fraction containing OT, while in two of the samples the RIA did show cross-reactivity with the third fraction, where AVP elutes (FIG. 2) . Therefore, the EIA was shown to be specific for OT in the prairie vole plasma, while the comparison RIA was less specific.
Salivary EIA Assay Methods
The same EIA used for the plasma validation in animal studies was used for the chemical validation of human salivary OT. The assay was validated for parallelism by assay of a serial dilution of pooled saliva samples. Quantitative recovery was examined to determine whether sample preparation methods adversely affected the results. Pooled salivary samples were spiked with varying amounts of standard of known concentration and then prepared for assay by concentration. Quantitative recovery was determined by comparing the assay results from the spiked samples to those for assay buffer spiked with the same volumes of standard. Precision was determined from the variability in multiple measurements of unknowns (intra-assay CV). A dilution series of pooled saliva resulted in a displacement curve parallel to that of the standard curve (y = 134.75-17.04×; r 2 = 0.94). Tests of quantitative recovery resulted in a high correlation between expected and observed values (y = 49.9 + 0.66×; r 2 = 0.99) and average recovery was 73%. Intra-assay CV averaged 2.1% and interassay CV values were 3.5% and 9.5% for high and low controls, respectively.
To allow measurement of salivary OT using a reliable portion of the standard curve, samples were concentrated prior to assay. After centrifugation, 1 mL of supernatant from each sample was dried by vacuum centrifugation and then reconstituted in 250 mL of assay buffer, resulting in a 4× sample.
Biological Validations of the Human Salivary OT Assay
Because of the well-established relationship between lactation and the synthesis of OT, we conducted validation studies for salivary OT in humans using saliva samples taken repeatedly from lactating women. In this study women (n = 10) provided 6 sets of 3 samples for a total of 180 samples. Samples were taken on two separate days at 30-min intervals before, during, and after breast feeding, and at three different times of day (morning, mid-day, and evening). Preliminary results indicated that OT concentrations in saliva samples (prior to concentration) were usually below the lowest standard. The results were FIGURE 3. In lactating women, salivary oxytocin measured by EIA was elevated 30 min prior to breast feeding, declined during the feeding, and rebounded within 30 min after feeding. * P <0.05 or higher. strikingly consistent (overall analysis of variance, P < 0.001 ; FIG. 3) . In every set of samples OT was highest prior to breast feeding, declined by the time of the actual breast feeding of the infant and in most women began to rise again 30 min after the feeding (P < 0.05 or higher in all paired comparisons). Time of day of saliva collection or repeated collection on two different days did not have a significant effect on either levels of OT or the pattern of change in OT.
In a preliminary study, samples of both blood and saliva were collected before and 30 min after upper body massages in different male subjects (n = 8) with three separate replicates for each subject for a total of 48 samples (FIG. 4) . In this study reliable, but relatively small increases in OT were detected following massage in both saliva and blood (P < 0.05).
One recent published study has reported that meaningful levels of OT could not be measured in saliva by EIA. 24 However, there are several methodological FIGURE 4. Oxytocin measured by EIA increased within 30 min following massage in saliva and blood in men. * P < 0.05. differences: the most important difference is that we quantitatively concentrate our samples fourfold to produce levels that are within the range of the EIA. Our study also avoided extractions, which can reduce the amount of measurable peptide.
In summary, this article supports the hypothesis that OT is present in human saliva. OT levels in saliva, measured by EIA, varied in a consistent pattern with relevant stimulation associated with lactation and massage. However, the amounts of OT present were low and the methods used here for concentrating samples are labor-intensive. A more sensitive assay is desirable, if salivary OT is to become a readily available "biomarker" for use in studies of human behavior or physiology.
